Cited by 1,699Circular RNAs in diseasesCancer-related molecular mechanisms researchRNA Research and Splicing

Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2

Open access
Du, William W., Yang, Weining, Liu, Elizabeth, Yang, Zhenguo, Dhaliwal, Preet, Yang, Burton B.·2016·Nucleic Acids Research

Abstract

Most RNAs generated by the human genome have no protein-coding ability and are termed non-coding RNAs. Among these include circular RNAs, which include exonic circular RNAs (circRNA), mainly found in the cytoplasm, and intronic RNAs (ciRNA), predominantly detected in the nucleus. The biological functions of circular RNAs remain largely unknown, although ciRNAs have been reported to promote gene transcription, while circRNAs may function as microRNA sponges. We demonstrate that the circular RNA circ-Foxo3 was highly expressed in non-cancer cells and were associated with cell cycle progression. Silencing endogenous circ-Foxo3 promoted cell proliferation. Ectopic expression of circ-Foxo3 repressed cell cycle progression by binding to the cell cycle proteins cyclin-dependent kinase 2 (also known as cell division protein kinase 2 or CDK2) and cyclin-dependent kinase inhibitor 1 (or p21), resulting in the formation of a ternary complex. Normally, CDK2 interacts with cyclin A and cyclin E to facilitate cell cycle entry, while p21works to inhibit these interactions and arrest cell cycle progression. The formation of this circ-Foxo3-p21-CDK2 ternary complex arrested the function of CDK2 and blocked cell cycle progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkw027

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • CircRNAs act as miRNA sponges by binding and inhibiting miRNAs, thereby regulating target gene expression at transcriptional and post-transcriptional levels.

    “Similar to competitive endogenous RNA (ceRNA), circRNAs act as sponges to bind and inhibit the activity of miRNAs [14], thus regulating the expression of target genes at the transcriptional and post-transcriptional levels through destabilization and translational silencing of mRNAs [15].”
  • circFoxo3 produces anti-proliferative effects and blocks cell cycle progression by weakening CDK2 activity through formation of the circFoxo3-p21-CDK2 ternary complex.

    “CircFoxo3 produces anti-proliferative effects and blocks cell cycle progression by weakening the activity of cyclin-dependent kinase 2 (CDK2) through formation of the circFoxo3-p21-CDK2 ternary complex [15].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Du, W. W., Yang, W., Liu, E., Yang, Z., Dhaliwal, P., & Yang, B. B.
Affiliations
Sunnybrook Health Science Centre (CA)
Corresponding author
  • Du, William W.
  • Yang, Weining
  • Yang, Burton B.
Venue
Nucleic Acids Research
Published
2016-02-09
Volume
44
Issue
6
Pages
2846-2858
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2266356262
Cited by
1,699
References
34
Citations by year
2026: 55 · 2025: 105 · 2024: 148 · 2023: 149 · 2022: 215 · 2021: 298 · 2020: 273 · 2019: 192 · 2018: 155 · 2017: 80 · 2016: 24
FWCI
78.11
Type
journal article
Language
en
Open access
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Circular RNAs in diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
Keywords
circular RNA, cell cycle progression, CDK2, p21, ternary complex, cyclin-dependent kinase inhibition, cell proliferation, non-coding RNA
MeSH terms
Forkhead Box Protein O3, Animals, Binding Sites, Cell Cycle, Cell Line, Cell Nucleus, Cytoplasm, Fibroblasts, Gene Expression Regulation, Humans, Nucleic Acid Conformation, Organ Specificity, Protein Binding, Signal Transduction, Cyclin A, Cyclin E, RNA, Untranslated, NIH 3T3 Cells, Cell Line, Tumor, Cell Proliferation, Cyclin-Dependent Kinase Inhibitor p21, Cyclin-Dependent Kinase 2, Mice, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review